The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
about
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Casp130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.
P2860
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@ast
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@en
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@nl
type
label
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@ast
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@en
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@nl
prefLabel
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@ast
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@en
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@nl
P2860
P356
P1433
P1476
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.
@en
P2093
Kristiina Vuori
P2860
P2888
P356
10.1186/1741-7007-9-73
P577
2011-10-28T00:00:00Z
P5875
P6179
1043968871